Test To Treat Tug-of-War: Pharmacy, Physician Groups Each Have Concerns With Biden COVID Plan

Community pharmacists say widespread implementation of Biden’s rapid pill dispensing initiative necessitates allowing pharmacists to prescribe Paxlovid and molnupiravir. But AMA worries that even clinic-based prescribing puts patients at risk because it bypasses primary care doctors.

Pharmacy
Community pharmacies face hurdles in implementing COVID-19 Test to Treat initiative • Source: Alamy

More from Distribution/Supply Chain

More from Compliance